89 related articles for article (PubMed ID: 2054791)
1. Expression of alpha-amylase isozymes in human thyroid tissues.
Doi S; Tomita N; Higasiyama M; Yokouchi H; Horii A; Yasuda T; Kobayashi T; Takai S; Ogawa M; Mori T
Cancer Res; 1991 Jul; 51(13):3544-9. PubMed ID: 2054791
[TBL] [Abstract][Full Text] [Related]
2. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical survey of amylase isoenzymes in cholangiocarcinoma and hepatocellular carcinoma.
Terada T; Nakanuma Y
Arch Pathol Lab Med; 1993 Feb; 117(2):160-2. PubMed ID: 8381270
[TBL] [Abstract][Full Text] [Related]
4. Expression of alpha-amylase in human lung cancers.
Tomita N; Matsuura N; Horii A; Emi M; Nishide T; Ogawa M; Mori T; Doi O; Matsubara K
Cancer Res; 1988 Jun; 48(11):3292-6. PubMed ID: 2835158
[TBL] [Abstract][Full Text] [Related]
5. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
6. Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?
Czarnocka B; Pastuszko D; Janota-Bzowski M; Weetman AP; Watson PF; Kemp EH; McIntosh RS; Asghar MS; Jarzab B; Gubala E; Wloch J; Lange D
Br J Cancer; 2001 Sep; 85(6):875-80. PubMed ID: 11556840
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.
Takano T; Matsuzuka F; Sumizaki H; Kuma K; Amino N
Cancer Res; 1997 Sep; 57(17):3792-7. PubMed ID: 9288789
[TBL] [Abstract][Full Text] [Related]
8. INSL-3 is expressed in human hyperplastic and neoplastic thyrocytes.
Hombach-Klonisch S; Hoang-Vu C; Kehlen A; Hinze R; Holzhausen HJ; Weber E; Fischer B; Dralle H; Klonisch T
Int J Oncol; 2003 May; 22(5):993-1001. PubMed ID: 12684664
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
15. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma].
Umeki K; Yamamoto I; Maruta J; Aratake Y; Ono I; Uemura Y; Tanaka T; Toyoda K; Kotani T; Noguchi S; Sakamoto F; Konoe K; Ohtaki S
Rinsho Byori; 1996 Jan; 44(1):42-50. PubMed ID: 8691639
[TBL] [Abstract][Full Text] [Related]
16. Expression of parathyroid hormone-related peptide in human thyroid tumours.
Nakashima M; Ohtsuru A; Luo WT; Nakayama T; Enomoto H; Usa T; Kiriyama T; Ito M; Nagataki S; Yamashita S
J Pathol; 1995 Feb; 175(2):227-36. PubMed ID: 7738719
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
18. Amylase in thyroid tissues from normal and various thyroid diseases. Biochemical and immunohistochemical study.
Mizukami Y; Matsubara F; Hashimoto T; Okumura J; Matsukawa S; Tanishima K
Acta Pathol Jpn; 1987 Feb; 37(2):253-60. PubMed ID: 2440230
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles in thyroid carcinomas.
Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
[TBL] [Abstract][Full Text] [Related]
20. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]